How Should the Value Attributes of Novel Antibiotics Be Considered in Reimbursement Decision Making?

Antibiotics have revolutionized the treatment of bacterial infections. However, it is widely held that there is underinvestment in antibiotics research and development relative to the socially optimal level for a number of reasons. In this article, we discuss whether existing health technology asses...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:MDM Policy Pract
Main Authors: Morton, Alec, Colson, Abigail, Leporowski, Axel, Trett, Anna, Bhatti, Taimur, Laxminarayan, Ramanan
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6935770/
https://ncbi.nlm.nih.gov/pubmed/31910245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2381468319892237
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki